Qiagen ( (QGEN) ) just unveiled an announcement.
Qiagen N.V. announced a release of voting rights as informed by the Netherlands Authority for the Financial Markets (AFM). The notification involves the Bank of America Corporation, detailing various transactions and holdings in Qiagen’s shares and voting rights. This announcement highlights the involvement of major financial institutions in Qiagen’s shareholding structure, potentially impacting its market positioning and stakeholder interests.
More about Qiagen
Qiagen N.V. is a company operating in the biotechnology industry, primarily focusing on providing sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company is known for its products that enable the isolation and processing of DNA, RNA, and proteins, catering to a wide range of markets including healthcare and scientific research.
YTD Price Performance: -9.32%
Average Trading Volume: 1,245,444
Technical Sentiment Signal: Strong Buy
Current Market Cap: $8.72B
For detailed information about QGEN stock, go to TipRanks’ Stock Analysis page.